Neostigmine Methylsulfate Injection
Product Images NDC 0641-6150

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 0641-6150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate Injection Anda 1)

Chemical structure of Neostigmine Methylsulfate showing the molecular arrangement including a quaternary ammonium group, benzene ring with methoxy substituent, and methylcarbamate functional group associated with the active ingredient.*

FDA Label Image

Logo (Neostigmine Methylsulfate Injection Anda 2)

Neostigmine Methylsulfate Injection, USP 5 mg per 10 mL (0.5 mg/mL) in a 10 mL multiple dose vial for intravenous use. The label includes active ingredient details, preservative information, storage instructions at controlled room temperature, and manufacturer Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Ndc 0641-6150-01 Rx Only Neostigmine Methylsulfate Injection, Usp 5 mg/10 mL (0.5 mg/ml) For Intravenous Use 10 mL Multiple Dose Vial Each mL Contains Neostigmine Methylsulfate 0.5 mg, Phenol 4.5 mg (used As A Preservative), Sodium Acetate Trihydrate 0.2 mg, Water For Injection; Ph Adjusted, When Necessary, With Sodium Hydroxide/acetic Acid. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store In Carton Until Time Of Use. (Neostigmine Methylsulfate Injection Anda 3)

Neostigmine Methylsulfate Injection, USP 0.5 mg/mL (5 mg per 10 mL) multiple dose vials. The label indicates the product is for intravenous use, with 10 x 10 mL vials in the package. It includes ingredients, storage instructions, and is manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

0.5 mg/ml 10 X 10 Shelfpack (Neostigmine Methylsulfate Injection Anda 4)

Neostigmine Methylsulfate Injection, USP 5 mg per 10 mL (0.5 mg/mL) in a multi-dose vial. Label shows active ingredient and concentration, indicated for intravenous use, with storage instructions and manufacturer information for Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Ndc 0641-6150-25 Rx Only Neostigmine Methylsulfate Injection, Usp 5 mg/10 mL (0.5 mg/ml) For Intravenous Use 25 X 10 mL Multiple Dose Vials Each mL Contains Neostigmine Methylsulfate 0.5 mg, Phenol 4.5 mg (used As A Preservative), Sodium Acetate Trihydrate 0.2 mg, Water For Injection; Ph Adjusted, When Necessary, With Sodium Hydroxide/acetic Acid. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store In Carton Until Time Of Use. (Neostigmine Methylsulfate Injection Anda 5)

Label for Neostigmine Methylsulfate Injection, USP, 10 mg per 10 mL (1 mg/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. The label includes dosage strength, usage route, preservative and ingredient details, storage instructions, and manufacturer information. It states this is a 10 mL multiple dose vial.*

FDA Label Image

Ndc 0641-6149-01 Rx Only Neostigmine Methylsulfate Injection, Usp 10 mg/10 mL (1 mg/ml) For Intravenous Use 10 mL Multiple Dose Vial Each mL Contains Neostigmine Methylsulfate 1 mg, Phenol 4.5 mg (used As A Preservative), Sodium Acetate Trihydrate 0.2 mg, Water For Injection; Ph Adjusted, When Necessary, With Sodium Hydroxide/acetic Acid. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store In Carton Until Time Of Use. (Neostigmine Methylsulfate Injection Anda 6)

Neostigmine Methylsulfate Injection label showing 10 mg per 10 mL (1 mg/mL) strength in a vial for intravenous use. The label includes concentration, prescribed usage info, storage instructions, and the labeler Hikma Pharmaceuticals USA Inc. It specifies the package count as 10 x 10 mL multiple dose vials and notes the product is Rx only.*

FDA Label Image

1 mg/ml 10 X 10 Shelfpack (Neostigmine Methylsulfate Injection Anda 7)

Neostigmine Methylsulfate Injection, USP 10 mg per 10 mL (1 mg/mL) label for intravenous use. The label indicates a 25 x 10 mL multiple dose vials package. It includes storage instructions to keep between 20° to 25°C (68° to 77°F) and to protect from light. The product is manufactured by Hikma Pharmaceuticals USA Inc. in Eatontown, NJ.*

FDA Label Image

Ndc 0641-6149-25 Rx Only Neostigmine Methylsulfate Injection, Usp 10 mg/10 mL (1 mg/ml) For Intravenous Use 25 X 10 mL Multiple Dose Vials Each mL Contains Neostigmine Methylsulfate 1 mg, Phenol 4.5 mg (used As A Preservative), Sodium Acetate Trihydrate 0.2 mg, Water For Injection; Ph Adjusted, When Necessary, With Sodium Hydroxide/acetic Acid. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store In Carton Until Time Of Use. (Neostigmine Methylsulfate Injection Anda 8)

Packaging label for Neostigmine Methylsulfate Injection by Hikma Pharmaceuticals USA Inc., showing key product identifiers including GTIN (00301234567896), serial number, expiration date placeholder, and lot number placeholder in a clear, structured format with a scannable QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.